602 CRITICAL AORTIC STENOSIS IN PROFOUND CARDIOGENIC SHOCH: BRIDGE TO TAVI WITH LEVOSIMENDAN.


 Cardiogenic shock (CS) in severe aortic stenosis (AS) is associated with high mortality. Percutaneous aortic valve implantation (TAVI) is a possible definite solution, but generally it cannot be performed on an emergency base. In patients with severe systolic dysfunction an augmentation of cardiac index (CI) during dobutamine and nitroprusside infusion can demonstrate contractile and afterload reserve. Invasive hemodynamic monitoring is necessary to keep optimal filling pressure and verify arterial pressure stability. If the hemodynamic response is positive we administer levosimendan to bridge the patient to decision and/or to TAVI. In our small experience this strategy is efficacy and well tolerated.